OpenAI details MedChemBench: 99 real research problems testing AI-assisted drug design
rohanpaul_ai · x · 2026-11-21
OpenAI published MedChemBench on its official blog, evaluating AI on medicinal chemistry reasoning: linking molecular structure changes to experimental evidence, explaining results, comparing compounds, and predicting properties.
- Core difficulty: improving one molecular property often worsens another (potent but poorly absorbed), which chemists navigate via design-make-test cycles
- The benchmark contains 99 problems drawn from published research; at xhigh reasoning GPT-6.2 Astra earned 84.5%, vs 83.3% for GPT-6 Astra, 82.0% for GPT-6.1 Sol, 58.2% for GPT-5.6 Sol
- GPT-6 Astra was strongest at reconstructing structures and explaining evidence; selecting compounds and predicting numerical properties proved harder
- OpenAI frames it as a step toward AI that reliably supports developing better medicines
This is the authoritative primary source for the release, with full benchmark details.
Related event: OpenAI Launches MedChemBench for AI Drug Chemistry Reasoning(4 posts)→
More from Research
- Vishal Sikka on reported Riemann Hypothesis proof with Claude: 'an incredible day' — vsikka · 2026-11-21
- Thinking Machines' 26B looped-MoE Inklings 2 Mini beats GLM-5.2 and Opus 4.5 on benchmarks — ziqiao_ma · 2026-11-21
- Bloomberg reporter claims AI may have cracked the Riemann Hypothesis — bgreene · 2026-11-21
- Interpretability competition launched to test logit lenses on Thinking Machines' Inkling — benno_krojer · 2026-11-21
- NDIF hosts Thinking Machines' Inkling 2 Mini and launches a Looped Lens interpretability challenge — benno_krojer · 2026-11-21
- OpenAI's GPT-Rosalind agents surface new drug discovery lead for neurodegenerative disease — OpenAI · 2026-11-21